Danaher to Present at J.P. Morgan Healthcare Conference
Rhea-AI Summary
Danaher (NYSE: DHR) has announced its participation in the upcoming J.P. Morgan Healthcare Conference in San Francisco. The company's President and CEO, Rainer M. Blair, will deliver a presentation on Tuesday, January 14, 2025 at 11:15 a.m. PT.
The presentation will be accessible to the public through a simultaneous webcast, which can be viewed on Danaher's website in the 'Investors' section under 'Events & Presentations' at www.danaher.com.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, DHR gained 0.38%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
ABOUT DANAHER
Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. Our businesses partner closely with customers to solve many of the most important health challenges impacting patients around the world. Danaher's advanced science and technology - and proven ability to innovate - help enable faster, more accurate diagnoses and help reduce the time and cost needed to sustainably discover, develop and deliver life-changing therapies. Focused on scientific excellence, innovation and continuous improvement, our approximately 63,000 associates worldwide help ensure that Danaher is improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow. Explore more at www.danaher.com.
View original content:https://www.prnewswire.com/news-releases/danaher-to-present-at-jp-morgan-healthcare-conference-302343009.html
SOURCE Danaher Corporation